BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 31519459)

  • 1. Advances and Challenges in Rational Drug Design for SLCs.
    Garibsingh RA; Schlessinger A
    Trends Pharmacol Sci; 2019 Oct; 40(10):790-800. PubMed ID: 31519459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting SLC transporters: small molecules as modulators and therapeutic opportunities.
    Schlessinger A; Zatorski N; Hutchinson K; Colas C
    Trends Biochem Sci; 2023 Sep; 48(9):801-814. PubMed ID: 37355450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiating SLC transporter activity: Emerging drug discovery opportunities.
    Rives ML; Javitch JA; Wickenden AD
    Biochem Pharmacol; 2017 Jul; 135():1-11. PubMed ID: 28214518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a novel microscale thermophoresis ligand-binding assay for characterization of SLC solute carriers using oligopeptide transporter PepT1 (SLC15 family) as a model system.
    Clémençon B; Lüscher BP; Hediger MA
    J Pharmacol Toxicol Methods; 2018; 92():67-76. PubMed ID: 29580877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Druggability of Solute Carriers.
    Wang WW; Gallo L; Jadhav A; Hawkins R; Parker CG
    J Med Chem; 2020 Apr; 63(8):3834-3867. PubMed ID: 31774679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease.
    Schumann T; König J; Henke C; Willmes DM; Bornstein SR; Jordan J; Fromm MF; Birkenfeld AL
    Pharmacol Rev; 2020 Jan; 72(1):343-379. PubMed ID: 31882442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification Systems of Secondary Active Transporters.
    Perland E; Fredriksson R
    Trends Pharmacol Sci; 2017 Mar; 38(3):305-315. PubMed ID: 27939446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Chemistry in Structure-Based Solute Carrier Transporter Drug Design: Recent Advances and Future Perspectives.
    Tu G; Fu T; Zheng G; Xu B; Gou R; Luo D; Wang P; Xue W
    J Chem Inf Model; 2024 Mar; 64(5):1433-1455. PubMed ID: 38294194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy.
    Hushmandi K; Einollahi B; Saadat SH; Lee EHC; Farani MR; Okina E; Huh YS; Nabavi N; Salimimoghadam S; Kumar AP
    Mol Metab; 2024 Jun; 84():101952. PubMed ID: 38705513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of solute carrier transporters in regulating dendritic cell maturation and function.
    Shao L; Yang M; Sun T; Xia H; Du D; Li X; Jie Z
    Eur J Immunol; 2024 Feb; 54(2):e2350385. PubMed ID: 38073515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SLC transporter in nutrient and metabolic sensing, regulation, and drug development.
    Zhang Y; Zhang Y; Sun K; Meng Z; Chen L
    J Mol Cell Biol; 2019 Jan; 11(1):1-13. PubMed ID: 30239845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and Synthesis of Hydroxy-l-Proline Blockers of the Neutral Amino Acid Transporters SLC1A4 (ASCT1) and SLC1A5 (ASCT2).
    Lyda BR; Leary GP; Farnsworth J; Seaver B; Silvius D; Kavanaugh MP; Esslinger CS; Natale NR
    Molecules; 2024 May; 29(10):. PubMed ID: 38792190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Structure and Mechanism of Drug Transporters.
    Roberts AG
    Methods Mol Biol; 2021; 2342():193-234. PubMed ID: 34272696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments in ligands and chemical probes targeting solute carrier transporters.
    Casiraghi A; Bensimon A; Superti-Furga G
    Curr Opin Chem Biol; 2021 Jun; 62():53-63. PubMed ID: 33689964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational exploration of fold atlas for human solute carrier proteins.
    Xie T; Chi X; Huang B; Ye F; Zhou Q; Huang J
    Structure; 2022 Sep; 30(9):1321-1330.e5. PubMed ID: 35700727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Solute Carrier Transporters in Glioma Pathology: A Comprehensive Review.
    Anagnostakis F; Kokkorakis M; Markouli M; Piperi C
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fruit fly Drosophila melanogaster as an innovative preclinical ADME model for solute carrier membrane transporters, with consequences for pharmacology and drug therapy.
    Wang Y; Moussian B; Schaeffeler E; Schwab M; Nies AT
    Drug Discov Today; 2018 Oct; 23(10):1746-1760. PubMed ID: 29890226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modeling and ligand docking for solute carrier (SLC) transporters.
    Schlessinger A; Khuri N; Giacomini KM; Sali A
    Curr Top Med Chem; 2013; 13(7):843-56. PubMed ID: 23578028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SLC Transporters: Structure, Function, and Drug Discovery.
    Colas C; Ung PM; Schlessinger A
    Medchemcomm; 2016 Jun; 7(6):1069-1081. PubMed ID: 27672436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural biology of solute carrier (SLC) membrane transport proteins.
    Bai X; Moraes TF; Reithmeier RAF
    Mol Membr Biol; 2017; 34(1-2):1-32. PubMed ID: 29651895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.